SGMTSagimet Biosciences Inc.vs its industry peers
A metric-by-metric comparison of Sagimet Biosciences Inc. against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SGMTEsta | — | — | — | — | — | -12.0%#4 | -2844.5%#5 | -19.9%#2 | — | — | 65.3%#3 | — |
| RMHI | — | — | — | — | — | -116.8%#8 | — | — | — | — | — | — |
| RPRX | — | 31.7x#1 | — | — | 5.1%#3 | -10.2%#3 | 65.6%#1 | 7.9%#1 | 8.7%#1 | — | 64.9%#4 | — |
| RVRC | — | — | — | — | — | — | — | -243.7%#8 | — | — | — | — |
| SDGR | — | — | — | — | 23.3%#2 | 44.8%#1 | -65.2%#3 | -31.4%#4 | — | — | 53.8%#5 | — |
| SKVI | — | — | — | — | 0.0%#4 | -88.1%#5 | -2481.6%#4 | — | — | — | — | — |
| SLGL | $182M#4 | — | 8.0x#1 | 9.4x#1 | 68.0%#1 | 42.1%#2 | -38.9%#2 | -26.9%#3 | -9.8%#2 | — | 171.9%#1 | — |
| SLN | $1.8B#3 | — | 46.8x#3 | 3224.0x#2 | -98.7%#5 | -95.6%#6 | -16292.8%#6 | -230.3%#6 | — | — | 155.3%#2 | — |
| SLNCF | — | — | — | — | -98.7%#5 | -95.6%#6 | -16292.8%#6 | -230.3%#6 | — | — | — | — |
| SMMT | $14.1B#2 | — | 22.4x#2 | — | — | -387.8%#9 | — | -171.4%#5 | — | — | -8.1%#6 | — |
| SMNR | — | — | — | — | — | -3320.4%#10 | — | — | — | — | — | — |
| SMNRW | — | — | — | — | — | -3320.4%#10 | — | — | — | — | — | — |
| SNY | $52.6B#1 | — | — | — | — | — | — | — | — | — | -9.6%#7 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-18.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice